CORRECTED-SEISMIC PHARMACEUTICALS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN GLOBAL PHASE 3 TRIAL OF ISTAROXIME IN CARDIOGENIC SHOCK (NOT 'COMMENCES GLOBAL PHASE 3 TRIAL')(SEPT 9)

Reuters · 1d ago

Please log in to view news